UAE launches Sinopharm vaccine trial for children under 18
The trial will monitor the immune response of 900 children "in preparation to vaccinate children… Read More
The trial will monitor the immune response of 900 children "in preparation to vaccinate children… Read More
China has approved four COVID-19 vaccines from domestic makers Sinopharm, Sinovac Biotech and CanSino Biologics,… Read More
The government says it will have 6 million AstraZenaca doses and 3 million Sinovac doses… Read More
Two COVID-19 vaccines from China’s Sinopharm showed more than 70% efficacy against symptomatic cases Read More
The jabs were to arrive in the country yesterday but got delayed due to some… Read More
The Sinopharm vaccines are being brought to Pakistan through a special plane from China, sources… Read More
Sources told ARY News that Pakistan has purchased the Sinopharm vaccines at a discounted price… Read More
China will provide another half a million doses of the vaccine Read More
China will provide 500,000 doses of its Sinovac coronavirus vaccine to Pakistan by January 31,… Read More
The Drug Regulatory Authority (DRAP) on Monday authorised China’s Sinopharm COVID-19 vaccine for emergency use… Read More
The Chinese vaccine firm has submitted complete data of the clinical trials of its vaccine… Read More
No detailed efficacy data of the vaccine has been publicly released Read More
It did not clarify whether approving it for registration meant that it would now be… Read More
In July, the Gulf Arab state started Phase III clinical trials of the vaccine, developed… Read More
Nearly one million people have taken an experimental coronavirus vaccine developed by Sinopharm through the… Read More
Brazil’s COVID-19 outbreak, the world’s worst outside the United States, has made it global testing… Read More
A coronavirus vaccine candidate developed by China National Pharmaceutical Group (Sinopharm) could be ready for… Read More
The vaccine, developed by a Wuhan-based research institute affiliated to CNBG’s parent company Sinopharm, was… Read More